共 12 条
[2]
Cutlip DE, 2001, CIRCULATION, V103, P1967
[5]
Newby K, 2001, CIRCULATION, V103, P1727
[6]
Long-term oral platelet glycoprotein IIb/IIIa receptor antagonism with sibrafiban after acute coronary syndromes: Study design of the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events post-acute cOroNary syndromes (SYMPHONY) trial
[J].
AMERICAN HEART JOURNAL,
1999, 138 (02)
:210-218
[9]
Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement - Analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial
[J].
CIRCULATION,
1997, 95 (08)
:2015-2021